StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report issued on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance NASDAQ:AKTX opened at $3.69 on Tuesday. Akari Therapeutics has a 12-month low of $2.81 and a 12-month high of $12.55. The stock’s […]
More Stories
Vanguard Growth ETF (NYSEARCA:VUG) Shares Sold by Northstar Advisory Group LLC
Northstar Advisory Group LLC lessened its holdings in shares of Vanguard Growth ETF (NYSEARCA:VUG – Free Report) by 5.9% in...
KONE Oyj (OTCMKTS:KNYJY) Short Interest Update
KONE Oyj (OTCMKTS:KNYJY – Get Free Report) was the target of a large drop in short interest in the month...
U.S. Global Investors, Inc. (NASDAQ:GROW) Declares $0.01 Dividend
U.S. Global Investors, Inc. (NASDAQ:GROW – Get Free Report) announced a dividend on Monday, January 13th,investing.com reports. Shareholders of record...
Israel Discount Bank Limited (OTCMKTS:ISDAY) Short Interest Update
Israel Discount Bank Limited (OTCMKTS:ISDAY – Get Free Report) was the recipient of a large decline in short interest in...
Canadian Natural Resources Limited (NYSE:CNQ) Short Interest Update
Canadian Natural Resources Limited (NYSE:CNQ – Get Free Report) (TSE:CNQ) was the recipient of a large decrease in short interest...
Mastercard Incorporated (NYSE:MA) Stock Holdings Lifted by Cardano Risk Management B.V.
Cardano Risk Management B.V. boosted its stake in Mastercard Incorporated (NYSE:MA – Free Report) by 2.7% during the 4th quarter,...